A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

Clinical trial NCT07214727 · RECRUITING

Trial details

NCT number: NCT07214727
Sponsor: Alnylam Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2025-10-15
Primary completion: 2030-03-06
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.